Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AM3101
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : Photon Fund
Deal Size : $4.0 million
Deal Type : Financing
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round
Details : The proceeds from the financing will enable Amplicore to complete the preclinical development of its two leading products, AM3101 and AM1101, and position the company for the next round of financing.
Product Name : AM3101
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
March 25, 2021
Lead Product(s) : AM3101
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : Photon Fund
Deal Size : $4.0 million
Deal Type : Financing